Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.24 -0.08 (-3.45%)
As of: Oct 23, 2026 · 3:50 PM EDT

Kiora Pharmaceuticals (KPRX) Income from Discontinued Operations (2022 - 2024)

Updated

Kiora Pharmaceuticals (KPRX) posted Income from Discontinued Operations of -$4.22 million for Q4 2024, compared with -$2.27 million a year earlier.

Analysis

Kiora Pharmaceuticals (KPRX) Income from Discontinued Operations (2022 - 2024) Analysis & Trends

For FY2024, Kiora Pharmaceuticals' Income from Discontinued Operations came in at $3.59 million.

  • In prior years, Kiora Pharmaceuticals' Income from Discontinued Operations was -$13.04 million in FY2023 and -$13.58 million in FY2022.
  • The Q4 2024 figure stands as the lowest quarterly Income from Discontinued Operations since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 8.00 Mn
10 Kiora Pharmaceuticals 13.84 Mn -53.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.22 Mn
Sep 30, 2024 -3.41 Mn
Dec 31, 2023 -2.27 Mn
Sep 30, 2023 -6.29 Mn
Dec 31, 2022 -2.50 Mn
Sep 30, 2022 -5.12 Mn
API Access

Kiora Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=KPRX&period=max&api_key=YOUR_API_KEY